Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid In Capital [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2022	$ (20,762)	$ 1	$ 67,739	$ (88,502)
Beginning Balances (in shares) at Dec. 31, 2022		507,987
Issuance of shares - equity line of credit, Shares		15,120
Issuance of shares - equity line of credit	1,108		1,108
Issuance of shares - commitment fee for equity line of credit, Shares		8,754
Issuance of shares - commitment fee for equity line of credit	1,000		1,000
Issuance of shares - prepaid forward contracts (As restated)	1,870		1,870
Stock-based compensation	505		505
Net loss	(7,096)			(7,096)
Ending Balance at Mar. 31, 2023	(23,375)	$ 1	72,222	(95,598)
Ending Balances (in shares) at Mar. 31, 2023		531,861
Beginning Balance at Dec. 31, 2022	(20,762)	$ 1	67,739	(88,502)
Beginning Balances (in shares) at Dec. 31, 2022		507,987
Net loss	(9,543)
Ending Balance at Jun. 30, 2023	(11,757)	$ 1	86,287	(98,045)
Ending Balances (in shares) at Jun. 30, 2023		724,850
Beginning Balance at Mar. 31, 2023	(23,375)	$ 1	72,222	(95,598)
Beginning Balances (in shares) at Mar. 31, 2023		531,861
Issuance of shares - equity line of credit, Shares		1,080
Issuance of shares - equity line of credit	55		55
Issuance of shares - prepaid forward contracts, Shares		43,879
Issuance of shares - conversion of convertible notes, Shares		123,527
Issuance of shares - conversion of convertible notes	1,936		1,936
Issuance of shares - vesting of RSUs		6,136
Forward Purchase Agreement Derivative Liability	11,519		11,519
Stock-based compensation	555		555
Stock-based compensation, Shares		18,367
Net loss	(2,447)			(2,447)
Ending Balance at Jun. 30, 2023	(11,757)	$ 1	86,287	(98,045)
Ending Balances (in shares) at Jun. 30, 2023		724,850
Beginning Balance at Dec. 31, 2023	(13,870)	$ 1	100,863	(114,734)
Beginning Balances (in shares) at Dec. 31, 2023		2,016,078
Issuance of shares - conversion of convertible notes, Shares		507,912
Issuance of shares - conversion of convertible notes	9,389		9,389
Issuance of shares - exercise of warrants, Shares		352,074
Issuance of shares - exercise of warrants	3,959		3,959
Issuance of shares - equity offerings, net of issuance costs, Shares		252,182
Issuance of shares - equity offerings, net of issuance costs	8,309		8,309
Stock-based compensation	434		434
Net loss	(12,697)			(12,697)
Ending Balance at Mar. 31, 2024	(4,476)	$ 1	122,954	(127,431)
Ending Balances (in shares) at Mar. 31, 2024		3,128,246
Beginning Balance at Dec. 31, 2023	(13,870)	$ 1	100,863	(114,734)
Beginning Balances (in shares) at Dec. 31, 2023		2,016,078
Net loss	(15,933)
Ending Balance at Jun. 30, 2024	(6,901)	$ 1	123,765	(130,667)
Ending Balances (in shares) at Jun. 30, 2024		3,221,104
Beginning Balance at Mar. 31, 2024	(4,476)	$ 1	122,954	(127,431)
Beginning Balances (in shares) at Mar. 31, 2024		3,128,246
Issuance of shares - conversion of convertible notes, Shares		92,858
Issuance of shares - conversion of convertible notes	826		826
Issuance costs - registration of previously issued warrants	(56)		(56)
Stock-based compensation	41		41
Net loss	(3,236)			(3,236)
Ending Balance at Jun. 30, 2024	$ (6,901)	$ 1	$ 123,765	$ (130,667)
Ending Balances (in shares) at Jun. 30, 2024		3,221,104